Fananserin (RP-62204) is a drug which acts as a potent antagonist at both the 5HT2A receptor and the Dopamine D4 receptor but without blocking other dopamine receptors such as D2. It has sedative and antipsychotic effects and has been researched for the treatment of schizophrenia although efficacy was less than expected and results were disappointing.
This page contains content from the copyrighted Wikipedia article "Fananserin"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
